Mental Health App for Depression in Cancer Survivors (MACS Trial)

N/A

Recruiting

Led By Earlise Ward, MS, PhD, LP

Research Sponsored by University of Wisconsin, Madison

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Age greater than or equal to 22 years at the time of consent

Be older than 18 years old

Must not have

Unable to read and speak English

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline, weekly during intervention from weeks 1 through 6, 1-month post intervention, 3-month post intervention (up to 20 weeks in total)

Awards & highlights

No Placebo-Only Group

Summary

This trial aims to test a digital app for mental health on head and neck cancer patients to help treat depression. Participants will use the app for 6 weeks and fill out surveys. "This trial tests

Who is the study for?

This trial is for adults over the age of 22 who have a history of head and neck cancer (HNC) confirmed by medical records. They must be experiencing moderate to severely moderate depression, with specific scores on a health questionnaire (PHQ-9). Participants need to commit to the study's procedures and timeline.

What is being tested?

The IONA Mind app, a digital mental health application, is being tested for its effectiveness in treating depression among patients and survivors of head and neck cancer. Users will engage with the app over six weeks while also completing related surveys.

What are the potential side effects?

As this intervention involves using a mental health app, side effects may not be as common as with medications but could include discomfort or emotional distress from engaging with content designed to address depressive symptoms.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 22 years old or older.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I cannot read or speak English.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline, weekly during intervention from weeks 1 through 6, 1-month post intervention, 3-month post intervention (up to 20 weeks in total)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline, weekly during intervention from weeks 1 through 6, 1-month post intervention, 3-month post intervention (up to 20 weeks in total)

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, weekly during intervention from weeks 1 through 6, 1-month post intervention, 3-month post intervention (up to 20 weeks in total) for reporting.